Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azfar Zaman

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2021
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear studyDavid E Kandzari, Ajay J Kirtane, Roxana Mehran, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear ResultsElvin Kedhi, Stephan Windecker, Azeem Latib, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 24, 2024
Frequency of periprocedural myocardial injury and infarction stratified by cardiac troponin I and cardiac troponin TPruthvi C Revaiah, Tsung-Ying Tsai, Bo Wang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerationsJ Wouter Jukema, Maddalena Lettino, Petr Widimský, et al.
JACC. Cardiovascular Interventions|September 24, 2021
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical TrialTiffany Patterson, Tim Clayton, Matthew Dodd, et al.
International Journal of Cardiology|April 6, 2020
Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysisAung Myat, Olympia Papachristofi, Uday Trivedi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomesMaddalena Lettino, Pontus Andell, Uwe Zeymer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registriesUwe Zeymer, Petr Widimsky, Nicolas Danchin, et al.
The American Journal of Cardiology|October 26, 2019
Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)Chun Chin Chang, Ernest Spitzer, Ply Chichareon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registriesNicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2021
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear studyDavid E Kandzari, Ajay J Kirtane, Roxana Mehran, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear ResultsElvin Kedhi, Stephan Windecker, Azeem Latib, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 24, 2024
Frequency of periprocedural myocardial injury and infarction stratified by cardiac troponin I and cardiac troponin TPruthvi C Revaiah, Tsung-Ying Tsai, Bo Wang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerationsJ Wouter Jukema, Maddalena Lettino, Petr Widimský, et al.
JACC. Cardiovascular Interventions|September 24, 2021
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical TrialTiffany Patterson, Tim Clayton, Matthew Dodd, et al.
International Journal of Cardiology|April 6, 2020
Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysisAung Myat, Olympia Papachristofi, Uday Trivedi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomesMaddalena Lettino, Pontus Andell, Uwe Zeymer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registriesUwe Zeymer, Petr Widimsky, Nicolas Danchin, et al.
The American Journal of Cardiology|October 26, 2019
Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)Chun Chin Chang, Ernest Spitzer, Ply Chichareon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registriesNicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
Pageof 15